DUBLIN (AP) — DUBLIN (AP) — Jazz Pharmaceuticals PLC (JAZZ) on Monday reported a loss of $483.4 million in its third quarter. The Dublin-based company said it had a loss of $7.48 per share. Losses, adjusted for one-time gains and costs, came to $3.88 per share. The results exceeded Wall Street expectations. The average estimate...